EP Patent

EP0112669A2 — Phenethylamine derivatives and intermediates therefor

Assigned to AHP PHARMA BV · Expires 1984-07-04 · 42y expired

What this patent protects

Novel phenethylamine derivatives are central nervous system antidepressants. The compounds are those having the formula <CHEM> where the dotted line represents optional unsaturation; R1 and R7 are, independently, hydrogen or C1-C6 alkyl; R2 is C1-C6 alkyl; R4 is hydroge…

USPTO Abstract

Novel phenethylamine derivatives are central nervous system antidepressants. The compounds are those having the formula <CHEM> where the dotted line represents optional unsaturation; R1 and R7 are, independently, hydrogen or C1-C6 alkyl; R2 is C1-C6 alkyl; R4 is hydrogen, C1-C4 alkyl, formyl or C2-C7 alkanoly; P5 and R6 are hydrogen or defined substituents and n is 0, 1, 2, 3, or 4 and their pharmaceutically acceptable salts. Novel intermediates for the preparation of these compounds include those of the formulae <CHEM> l

Drugs covered by this patent

Patent Metadata

Patent number
EP0112669A2
Jurisdiction
EP
Classification
—
Expires
1984-07-04
Drug substance claim
No
Drug product claim
No
Assignee
AHP PHARMA BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.